Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
indapamide hemihydrate,perindopril erbumine
Lupin Australia Pty Limited
indapamide hemihydrate,Perindopril erbumine
Registered
CONSUMER MEDICINE INFORMATION PERINDOPRIL AND INDAPAMIDE-GH 4/1.25 (PERINDOPRIL ERBUMINE AND INDAPAMIDE HEMIHYDRATE) TABLET WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Perindopril and Indapamide-GH 4/1.25 mg tablets. It does not contain all the available information about this medicine. Reading this leaflet does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Perindopril and Indapamide-GH 4/1.25 mg tablets against the expected benefits for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT PERINDOPRIL AND INDAPAMIDE-GH 4/1.25 IS USED FOR The name of your medicine is Perindopril and Indapamide-GH 4/1.25 mg tablets. The medicine contains the active ingredients perindopril erbumine and indapamide hemihydrate. Perindopril belongs to a group of medicines called angiotensin converting enzyme (ACE) inhibitors. Indapamide belongs to a group of medicines called diuretics (a type of “water” tablet). YOU HAVE BEEN PRESCRIBED PERINDOPRIL AND INDAPAMIDE- GH 4/1.25 MG TABLETS FOR HIGH BLOOD PRESSURE. Perindopril and Indapamide-GH 4/1.25 mg tablets are available only with a doctor's prescription. There is no evidence that Perindopril and Indapamide-GH 4/1.25 mg tablets are addictive. _WHY PERINDOPRIL AND _ _INDAPAMIDE-GH 4/1.25 MG _ _TABLETS 4/1.25 MG IS USED _ _FOR HIGH BLOOD PRESSURE _ Everyone has blood pressure. This pressure helps to circulate blood all around the body. Your blood pressure may be different at different times of the day, depending on how busy or stressed you are. You have high blood pressure (also known as hypertension) when your blood pressure stays higher than is needed, even when you are calm and relaxed. If high blood pressure is not treated it can lead to serious health problems. You may feel fine and have no symptoms, but eventually it can cause stroke, heart dis Read the complete document
AUSTRALIAN PRODUCT INFORMATION – PERINDOPRIL AND INDAPAMIDE-GH 4/1.25 (PERINDOPRIL ERBUMINE AND INDAPAMIDE HEMIHYDRATE) TABLET 1 NAME OF THE MEDICINE Perindopril erbumine and indapamide hemihydrate. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Perindopril and Indapamide GH 4/1.25 mg tablets containing perindopril erbumine 4 mg and indapamide hemihydrate 1.25 mg List of excipients with known effect: Lactose monohydrate. For the full list of excipients, see SECTION 6.1 LIST OF EXCIPIENTS. 3 PHARMACEUTICAL FORM Perindopril and Indapamide GH 4/1.25 mg tablets are white to off-white; capsule shaped uncoated tablets, plain on both sides. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS TREATMENT OF HYPERTENSION: Treatment should not be initiated with this combination. 4.2 DOSE AND METHOD OF ADMINISTRATION Note that Perindopril and Indapamide GH is not available in a 2/0.625 mg strength. Other brands should be used if this dose strength is required. One Perindopril and Indapamide GH 4/1.25 tablet per day as a single dose, preferably to be taken in the morning. ELDERLY PATIENTS Renal insufficiency is commonly observed in elderly people. Care should therefore be taken when prescribing perindopril-containing medicines to elderly hypertensive patients. The initial dose in the elderly should always be one tablet of the perindopril 2 mg/ indapamide 0.625 mg fixed dose combination product daily, and patients should be monitored closely during the initial stages of treatment. Perindopril and Indapamide GH 4/1.25 v5.0 Page 2 of 35 (perindopril erbumine and indapamide hemihydrate) tablet Particular care should be taken in elderly patients with congestive heart failure who have renal and/or hepatic insufficiency (see SECTION 4.4. SPECIAL WARNINGS AND PRECAUTIONS FOR USE). PATIENTS WITH RENAL INSUFFICIENCY In cases of severe renal insufficiency (creatinine clearance below 30 mL/min), the treatment is contraindicated. In patients with moderate renal insufficiency (creatinine clearance 30-60 mL/min), the maximum dose should be one Read the complete document